Showing results (211-220 of 521) with videos related to
Sort By:
Pageof 53
American Journal of Physiology. Renal Physiology|June 14, 2018
Dual gain and loss of cullin 3 function mediates familial hyperkalemic hypertensionRyan J Cornelius, Chong Zhang, Kayla J Erspamer, et al.Journal of the American Society of Nephrology : JASN|November 16, 2013
Protein phosphatase 1 inhibitor-1 deficiency reduces phosphorylation of renal NaCl cotransporter and causes arterial hypotensionNicolas Picard, Katja Trompf, Chao-Ling Yang, et al.European Journal of Heart Failure|June 7, 2019
Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failureG Michael Felker, Maria Borentain, John G Cleland, et al.American Heart Journal|March 5, 2019
Utilizing mobile technologies to improve physical activity and medication adherence in patients with heart failure and diabetes mellitus: Rationale and design of the TARGET-HF-DM TrialAbhinav Sharma, Robert J Mentz, Bradi B Granger, et al.Current Cardiology Reports|March 29, 2024
Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac ConditionsJosephine Harrington, G Michael Felker, James L Januzzi, et al.Journal of Cardiac Failure|August 17, 2004
The impact of arrhythmias in acute heart failureRaymond L Benza, José A Tallaj, G Michael Felker, et al.ESC Heart Failure|December 24, 2024
Design and rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA-HF)Jan Biegus, JoAnn Lindenfeld, G Michael Felker, et al.JACC. Heart Failure|August 18, 2020
In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United StatesStephen J Greene, Taylor S Triana, Raluca Ionescu-Ittu, et al.Lancet (London, England)|March 31, 2009
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb studyJohn R Teerlink, Marco Metra, G Michael Felker, et al.Journal of the American Heart Association|February 20, 2017
Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection FractionOmar F AbouEzzeddine, Paul M McKie, Shannon M Dunlay, et al.Pageof 53